203 related articles for article (PubMed ID: 16288851)
1. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
Kos T; Popik P; Pietraszek M; Schäfer D; Danysz W; Dravolina O; Blokhina E; Galankin T; Bespalov AY
Eur Neuropsychopharmacol; 2006 May; 16(4):297-310. PubMed ID: 16288851
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects associated with chronic ketamine or remacemide exposure in rats.
Wright LK; Pearson EC; Hammond TG; Paule MG
Neurotoxicol Teratol; 2007; 29(3):348-59. PubMed ID: 17291718
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Kankaanpää A; Meririnne E; Seppälä T
Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
[TBL] [Abstract][Full Text] [Related]
4. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
[TBL] [Abstract][Full Text] [Related]
5. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Ramamoorthy R; Radhakrishnan M; Borah M
Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
Liu W; Thielen RJ; McBride WJ
Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
9. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice.
da Silva FC; do Carmo de Oliveira Cito M; da Silva MI; Moura BA; de Aquino Neto MR; Feitosa ML; de Castro Chaves R; Macedo DS; de Vasconcelos SM; de França Fonteles MM; de Sousa FC
Brain Res Bull; 2010 Aug; 83(1-2):9-15. PubMed ID: 20600677
[TBL] [Abstract][Full Text] [Related]
10. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
11. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
Bubeníková-Valesová V; Votava M; Pálenícek T; Horácek J
Neuropharmacology; 2007 Mar; 52(4):1071-8. PubMed ID: 17196227
[TBL] [Abstract][Full Text] [Related]
12. Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
Wiley JL; Balster RL
Life Sci; 2004 May; 75(2):141-51. PubMed ID: 15120567
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
Pitsikas N; Zisopoulou S; Pappas I; Sakellaridis N
Behav Brain Res; 2008 Apr; 188(2):304-9. PubMed ID: 18164078
[TBL] [Abstract][Full Text] [Related]
14. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
[TBL] [Abstract][Full Text] [Related]
15. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
Hillhouse TM; Porter JH
Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
[TBL] [Abstract][Full Text] [Related]
16. The multiple effects of ketamine on electroencephalographic activity and behavior in WAG/Rij rats.
Midzyanovskaya IS; Salonin DV; Bosnyakova DY; Kuznetsova GD; van Luijtelaar EL
Pharmacol Biochem Behav; 2004 Sep; 79(1):83-91. PubMed ID: 15388287
[TBL] [Abstract][Full Text] [Related]
17. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
19. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
Yoo JH; Nam YS; Lee SY; Jang CG
Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
[TBL] [Abstract][Full Text] [Related]
20. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
David HN; Ansseau M; Lemaire M; Abraini JH
Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
